New 52 Week High Today

NanoViricides Inc NNVC:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:22 PM EDT
2.16quote price arrow down-0.07 (-3.14%)
Volume
7,328
Close
2.23quote price arrow up+0.43 (+23.89%)
Volume
592,021
52 week range
1.00 - 2.29
Loading...
  • Open1.89
  • Day High2.29
  • Day Low1.86
  • Prev Close1.80
  • 52 Week High2.29
  • 52 Week High Date05/16/24
  • 52 Week Low1.00
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap26.267M
  • Shares Out11.78M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change118.63

KEY STATS

  • Open1.89
  • Day High2.29
  • Day Low1.86
  • Prev Close1.80
  • 52 Week High2.29
  • 52 Week High Date05/16/24
  • 52 Week Low1.00
  • 52 Week Low Date11/13/23
  • Market Cap26.267M
  • Shares Out11.78M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change118.63

RATIOS/PROFITABILITY

  • EPS (TTM)-0.80
  • P/E (TTM)-2.78
  • Fwd P/E (NTM)-5.72
  • EBITDA (TTM)-8.948M
  • ROE (TTM)-57.90%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NanoViricides Inc

 

Profile

MORE
NanoViricides, Inc. is a development stage company, which is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-CoV-2 (API NV-387) for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. Its other advanced candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 is its...
Anil Diwan Ph.D.
President, Chief Executive Officer, Executive Chairman of the Board
Meeta Vyas
Chief Financial Officer
Address
1 Controls Drive
Shelton, CT
06484
United States

Top Peers

SYMBOLLASTCHG%CHG
VINC
Vincerx Pharma Inc
0.72-0.0279-3.7304%
PYPD
PolyPid Ltd
4.35-0.39-8.23%
SRZN
Surrozen Inc
9.91-0.24-2.39%
LSTA
Lisata Therapeutics Inc
2.73-0.11-4.02%
NRBO
NeuroBo Pharmaceuticals Inc
4.56+0.32+7.55%